ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.590,59
-0,50%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
-0,55%
Euro vs US Dollar
1,08328
-0,19%
Bitcoin
67.820,51
-0,69%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Forward Pharma AS (FWP)

  7. Forward Pharma AS (FWP) News

FWP

Forward Pharma AS (FWP)

Forward Pharma AS
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FWP
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202322h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
24/01/202312h08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
13/01/202322h43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
06/01/202315h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FWPForward Pharma AS
19/12/202212h04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
19/12/202212h00GlobeNewswire Inc.Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketNASDAQ:FWPForward Pharma AS
06/12/202220h24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
06/12/202220h00GlobeNewswire Inc.Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewNASDAQ:FWPForward Pharma AS
21/11/202223h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
09/11/202222h47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
07/07/202222h35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
20/05/202222h36Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
05/05/202223h40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
02/05/202222h56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
08/04/202223h25GlobeNewswire Inc.Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021NASDAQ:FWPForward Pharma AS
14/02/202218h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
27/12/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
13/12/202123h04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FWPForward Pharma AS
13/12/202123h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FWPForward Pharma AS
12/10/202123h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
07/09/202113h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
06/09/202116h21GlobeNewswire Inc.Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingNASDAQ:FWPForward Pharma AS
08/06/202123h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
28/05/202114h00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
27/05/202123h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
04/05/202112h08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
15/04/202123h07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
15/04/202123h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
14/04/202122h40GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020NASDAQ:FWPForward Pharma AS
14/04/202122h20Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FWPForward Pharma AS
 Showing the most relevant articles for your search:NASDAQ:FWP

Kürzlich von Ihnen besucht

LSE
99AO
Corp Andina 25
BIT
P1MK38
BNP Paribas Issuance
NYSE
YTPG
TPG Pace Beneficial II
BIT
P41114
Bnp Paribas Issuance
BIT
P1WL50
NLBNPIT1WL50 20991231 15...
BIT
PRL
Pierrel
BIT
F18263
Vontobel Financial Produ...
UPBT
OMGKRW
OMG Network
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten